# Tianjin Zhongan Pharmaceutical Co., Ltd. – FDA Inspection, Jun 24, 2010

Source: https://www.keypedia.com/records/fda_inspections/tianjin-zhongan-pharmaceutical-co-ltd/1b06b7b1-61a5-47e6-9171-cb1341daf39a
Source feed: FDA_Inspections

> FDA inspection 672160 of Tianjin Zhongan Pharmaceutical Co., Ltd., June 24, 2010. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 672160
- Company Name: Tianjin Zhongan Pharmaceutical Co., Ltd.
- Inspection Date: 2010-06-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1289190 - 2025-10-23
- [FDA Inspection 956512 - 2016-02-02](https://www.keypedia.com/records/fda_inspections/tianjin-zhongan-pharmaceutical-co-ltd/17c57f4f-0a27-4b9f-8777-95adb60ba223)
- [FDA Inspection 851023 - 2013-09-27](https://www.keypedia.com/records/fda_inspections/tianjin-zhongan-pharmaceutical-co-ltd/86e3ccbf-4fea-4a10-bb77-98dea07bee72)

Company: https://www.keypedia.com/companies/tianjin-zhongan-pharmaceutical-co-ltd/cfcbf49f-bdcb-4520-bcee-c05217237980

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c